Clinical Trial Update: Citalopram Titration in Early Non-responder Patients With Major Depressive Disorders [Phase 2]

View source ↗

Summary

Phase 2 clinical trial updating citalopram titration in early non-responders with major depressive disorder.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Major Depressive Disorder

Drugs mentioned

• Citalopram (Citalopram hydrobromide)

Snippet

Sponsor: Ciusss de L'Est de l'Île de Montréal | Conditions: Major Depressive Disorder | Phase 2 | Status: COMPLETED